NCT07616947

Brief Summary

Broken bones in the hand are common injuries that can make it hard to move fingers, grip objects, and return to work. When these breaks happen in the long bones of the hand (called metacarpals and phalanges), surgery is often needed to hold the bones in the right place while they heal. There are a few different ways surgeons can fix these broken bones. Two common methods are: CRPP (Closed Reduction and Percutaneous Pinning): The bones are moved back into place without opening the skin, and thin metal pins are used to hold them. IMSF (Intramedullary Screw Fixation): A small screw is placed inside the bone to hold it in position. Another approach sometimes used for larger bones in the hand is ORIF (Open Reduction and Internal Fixation), where the bone is exposed through a small incision and held with plates or screws. This study will compare how well these methods work. Investigators want to find out if using an intramedullary screw (IMSF) helps patients heal faster and move their hands more easily compared to the other common methods (CRPP and ORIF). Investigators will look at how quickly patients regain movement, how soon they can return to work, how satisfied they are with their recovery, and whether there are any problems or complications from surgery. To do this, investigators will run a randomized controlled trial-this means patients will be stratified based on fracture location (metacarpals or phalanges) and randomly assigned to a treatment arm. For patients with metacarpal fractures, investigators will compare IMSF vs CRPP vs ORIF using a dorsal plate. For patients with proximal or middle phalangeal fractures investigators will compare IMSF to CRPP. Investigators will measure their recovery using both clinical tests and patient surveys over time. The results of this research will help surgeons choose the best and safest way to treat hand fractures so patients can heal faster and get back to their daily lives sooner

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
38mo left

Started Sep 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 14, 2026

Completed
18 days until next milestone

First Posted

Study publicly available on registry

June 1, 2026

Completed
3 months until next milestone

Study Start

First participant enrolled

September 1, 2026

Expected
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2028

1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2029

Last Updated

June 1, 2026

Status Verified

May 1, 2026

Enrollment Period

2 years

First QC Date

May 14, 2026

Last Update Submit

May 26, 2026

Conditions

Outcome Measures

Primary Outcomes (3)

  • Range of Motion

    Measure and compare Range of Motion pre and post operatively

    from enrollment to the of end of the study at 12 months

  • Grip strength

    Measure and compare grip strength, in Kilograms, pre and post operatively

    from enrollment to the of end of the study at 12 months

  • Visual Analogue Scale for pain

    The Visual Analog Scale (VAS) for pain is a standardized, subjective tool used to measure pain intensity. It consists of a straight 10-cm (100-mm) horizontal line anchored at one end by "no pain" and at the other by "the worst pain imaginable." Measure and compare patient reported VAS pre and post operatively.

    from enrollment to the of end of the study at 12 months

Secondary Outcomes (6)

  • Return to Work

    from enrollment to the of end of the study at 12 months

  • Complications

    from enrollment to the of end of the study at 12 months

  • Quick Dash,the Quick Disabilities of the Arm, Shoulder, and Hand

    from enrollment to the of end of the study at 12 months

  • Single assessment numeric evaluation (SANE)

    from enrollment to the of end of the study at 12 months

  • EuroQol 5-Dimensional questionnaire

    from enrollment to the of end of the study at 12 months

  • +1 more secondary outcomes

Study Arms (3)

Open Reduction and Internal Fixation

EXPERIMENTAL

patients with metacarpal fractures, we will compare IMSF vs CRPP vs ORIF using a dorsal plate

Procedure: ORIF

Closed Reduction and Percutaneous Pinning

EXPERIMENTAL

we will compare proximal or middle phalangeal fractures treated with IMSF to those treated with CRPP patients with metacarpal fractures, we will compare IMSF vs CRPP vs ORIF using a dorsal plate

Procedure: CRPP

Intramedullary Screw Fixation

EXPERIMENTAL

we will compare proximal or middle phalangeal fractures treated with IMSF to those treated with CRPP patients with metacarpal fractures, we will compare IMSF vs CRPP vs ORIF using a dorsal plate

Procedure: IMSF

Interventions

ORIFPROCEDURE

Open Reduction and Internal Fixation

Also known as: CRPP
Open Reduction and Internal Fixation
IMSFPROCEDURE

Intramedullary Screw Fixation

Intramedullary Screw Fixation
CRPPPROCEDURE

Closed Reduction and Percutaneous Pinning

Closed Reduction and Percutaneous Pinning

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The MC arm:
  • surgical management within 10 days of injury
  • extraarticular fractures, clinical scissoring
  • sagittal angulation in accordance with accepted norms (Table 1)
  • shortening \>5mm, translation \>50%.
  • The phalangeal arm:
  • surgical management within 10 days of injury
  • extraarticular fractures, clinical scissoring
  • sagittal angulation \>20°
  • shortening \>2mm
  • translation \>50%.

You may not qualify if:

  • \< 18 years old
  • unable to read English, provide consent, or return to follow-up.
  • Injuries with concomitant soft tissues loss, tendon injury, nerve injury, infection, or fractures with severe comminution
  • history of prior surgical management of a fracture of the ipsilateral hand

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. Joseph's Health Care London

London, Ontario, N6A 4V2, Canada

Location

Study Officials

  • Spencer B Chambers

    Western University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Patients will be stratified based on fracture, metacarpals or phalanges. For the metacarpal group, we will use a1:1:1 randomization ratio (ORIF vs CRPP vs IMSF) using blocks of 9. For the phalangeal group, we will use a 1:1 ratio (CRPP vs IMSF) in blocks of 8.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Surgeon, Assistant Professor

Study Record Dates

First Submitted

May 14, 2026

First Posted

June 1, 2026

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

September 1, 2028

Study Completion (Estimated)

October 1, 2029

Last Updated

June 1, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations